Nano-X Imaging Ltd

NNOX remains in a Stage 4 decline with confirmed lower highs and lower lows under declining EMAs. The recent volume-backed bounce from extreme oversold conditions has provided relief but not reversed the downtrend. Price is extended below the 9/21/50-day EMA cluster, and the speculative approach favors trimming into rallies toward these overhead EMAs rather than initiating new shorts at current levels.

• ↑Affordable X-ray technology addresses large unmet imaging demand.
• ↑Q1 2026 revenue of $4.3 M signals initial commercial traction.
• ↓Q1 net loss of $14.3 M and withdrawn revenue guidance jeopardize operations.